Tuesday
Downgrade
Roth MKM downgraded Rain…
Roth MKM downgraded Rain Oncology to Neutral from Buy with a $1.20 price target after the company announced it will suspend enrollment in the ongoing milademetan Phase 2 MANTRA-2 basket trial and has terminated plans for initiation of the Phase 1/2 MANTRA-4 combination trial while assessing prospects for broadening its pipeline based on precision oncology. The firm is removing milademetan from its valuation based on the update, the analyst noted.
Show Hide Related Items >> <<
05/30/23 Rain Oncology cofounder Robert Doebele to assume role of CMO 05/30/23 Rain Oncology provides update, outlines priorities for milademetan program 05/22/23 Rain Oncology Phase 3 MANTRA trial did not meet primary endpoint 01/23/23 Rain Oncology announces publication of Phase 1 data of milademetan 05/23/23 H.C. Wainwright Rain Oncology downgraded to Neutral from Buy at H.C. Wainwright 05/23/23 Oppenheimer Rain Oncology downgraded to Perform on Phase 3 failure at Oppenheimer 05/23/23 Citi Rain Oncology downgraded to Neutral from Buy at Citi 05/22/23 Oppenheimer Rain Oncology downgraded to Perform from Outperform at Oppenheimer 05/11/23 Rain Oncology reports Q1 EPS (56c), consensus (61c) 03/09/23 Rain Oncology reports Q4 EPS (70c), consensus (56c) 05/23/23 What You Missed On Wall Street On Tuesday 05/23/23 What You Missed On Wall Street This Morning 05/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/22/23 What You Missed On Wall Street On Monday 05/30/23 Largest borrow rate increases among liquid names
Options
Latest data shows the…
Latest data shows the largest indicative borrow rate increases among liquid option names include: First Republic Bank (FRCB) 42.75% +17.11, Cipher Mining (CIFR) 45.84% +11.33, Nikola (NKLA) 83.45% +5.61, Rain Therapeutics (RAIN) 15.69% +3.43, Prometheus Biosciences (RXDX) 3.67% +3.41, Microvast Holdings (MVST) 5.17% +2.44, Atomera (ATOM) 11.22% +2.23, SPDR S&P Biotech (XBI) 6.07% +2.07, Nordstrom (JWN) 4.68% +1.98, and Rumble (RUM) 37.69% +1.94.
Show Hide Related Items >> <<
05/16/23 Prometheus, Seagen slip after FTC sues to block Horizon acquisition 04/16/23 Fly Intel: Top five weekend stock stories 04/16/23 Merck acquires Prometheus Biosciences for $200 per share 12/07/22 Prometheus announces results for PRA023 in APOLLO-CD Phase 2 study 05/18/23 Rumble launches alpha release of Creator Sponsorship Marketplace 05/16/23 Culper Research calls Rumble 'unraveling stock promotion', remains short 04/27/23 Rumble down 4% to $7.81 after Culper Research short report 04/12/23 Rumble partners with RNC to stream first GOP debate of 2024 primaries 05/30/23 Rain Oncology cofounder Robert Doebele to assume role of CMO 05/30/23 Rain Oncology provides update, outlines priorities for milademetan program 05/22/23 Rain Oncology Phase 3 MANTRA trial did not meet primary endpoint 01/23/23 Rain Oncology announces publication of Phase 1 data of milademetan 05/25/23 Nikola under pressure after receiving delisting notice 05/24/23 Nikola encourages stockholders to vote for Proposal 2 05/09/23 Nikola shares plunge 15% after quarterly report, exit from European JV 05/09/23 Nikola: Coolidge Phase 2 assembly hall expansion on track for end of Q2 04/13/23 Microvast announces appointment of Isida Tushe as general counsel 03/15/23 Microvast selected by MAFI & TREPEL as battery supplier for EV tractors 12/07/22 Microvast secures contract to supply BESS to U.S. customer 05/10/23 Nordstrom names Cathy Smith as CFO, effective May 29 04/17/23 Nordstrom appoints Eric Sprunk to Board of Directors 04/17/23 Tilly's names Laura Janney as EVP, Chief Merchandising Officer 04/14/23 Nordstrom appoints Jason Morris as Chief Technology and Information Officer 05/25/23 CRE exposure may pressure ratings of regional banks, Fitch Ratings says 05/01/23 Cipher Mining mines 406 bitcoin in April 03/20/23 Cipher names Patrick Kelly and Will Iwaschuk co- presidents, Stennett as CAO 01/10/23 Cipher Mining ends 2022 with 394 Bitcoin 12/20/22 Cipher Mining acquires additional new mining rigs for Odessa data center 04/26/23 Atomera jumps 40% to $7.32 after entering pact with STMicroelectronics 04/26/23 Atomera signs commercial license agreement with STMicroelectronics 03/12/23 Atomera says not materially impacted by Silicon Valley Bank closure 01/12/23 Atomera collaborates with Arizona State over semiconductor material advancement 04/25/23 Canaccord Cipher Mining initiated with a Buy at Canaccord 03/14/23 Cantor Fitzgerald Cipher Mining initiated with an Overweight at Cantor Fitzgerald 03/13/23 Cantor Fitzgerald Cipher Mining initiated with an Overweight at Cantor Fitzgerald 02/21/23 Needham Cipher Mining initiated with a Buy at Needham 05/10/23 TD Cowen TD Cowen downgrades Nikola to Market Perform on persistent liquidity overhang 05/09/23 TD Cowen Nikola downgraded to Market Perform from Outperform at TD Cowen 03/31/23 BTIG BTIG downgrades Nikola to Neutral after stock offering, expects further dilution 03/31/23 BTIG Nikola downgraded to Neutral from Buy at BTIG 05/23/23 H.C. Wainwright Rain Oncology downgraded to Neutral from Buy at H.C. Wainwright 05/23/23 Oppenheimer Rain Oncology downgraded to Perform on Phase 3 failure at Oppenheimer 05/23/23 Citi Rain Oncology downgraded to Neutral from Buy at Citi 05/22/23 Oppenheimer Rain Oncology downgraded to Perform from Outperform at Oppenheimer 05/10/23 Jefferies Prometheus downgraded to Hold from Buy at Jefferies 04/18/23 Wells Fargo Prometheus downgraded to Equal Weight from Overweight at Wells Fargo 04/18/23 RBC Capital Prometheus downgraded to Sector Perform from Outperform at RBC Capital 04/17/23 Credit Suisse Prometheus downgraded to Neutral from Outperform at Credit Suisse 04/03/23 H.C. Wainwright Microvast initiated with a Buy at H.C. Wainwright 08/18/22 Oppenheimer Oppenheimer starts Microvast with Outperform, $8 price target 08/18/22 Oppenheimer Microvast initiated with an Outperform at Oppenheimer 04/27/23 Craig-Hallum Atomera price target raised to $17 from $13 at Craig-Hallum 11/10/22 Craig-Hallum Atomera price target lowered to $13 from $22 at Craig-Hallum 05/25/23 Citi Nordstrom price target lowered to $17 from $20 at Citi 05/02/23 Barclays Nordstrom price target lowered to $14 from $16 at Barclays 03/08/23 Argus Nordstrom upgraded to Buy from Hold at Argus 03/03/23 Morgan Stanley Nordstrom assumed with an Underweight at Morgan Stanley 05/16/23 DA Davidson Rumble price target lowered to $12 from $15 at DA Davidson 12/02/22 Oppenheimer Rumble initiated with a Perform at Oppenheimer 05/09/23 Prometheus reports Q1 EPS (86c), consensus (91c) 02/28/23 Prometheus reports Q4 EPS (90c), consensus (92c) 05/16/23 Rumble reports Q1 EPS (14c) vs. (2c) last year 03/30/23 Rumble reports Q4 EPS 0c, two estimates (2c) 05/11/23 Rain Oncology reports Q1 EPS (56c), consensus (61c) 03/09/23 Rain Oncology reports Q4 EPS (70c), consensus (56c) 05/09/23 Nikola reports Q1 adjusted EPS (26c), consensus (26c) 05/08/23 Notable companies reporting before tomorrow's open 02/23/23 Nikola reports Q4 adjusted EPS (37c), consensus (43c) 05/09/23 Microvast sees Q2 revenue $63M-$67M 05/09/23 Microvast raises FY23 revenue view to $348M-$368M 03/02/23 Nordstrom reports Q4 EPS 74c, consensus 66c 03/02/23 Nordstrom sees FY23 adjusted EPS $1.80-$2.20, consensus $1.93 03/02/23 Notable companies reporting after market close 01/19/23 Nordstrom cuts FY22 adjusted EPS view to $1.50-$1.70 from $2.30-$2.60 05/09/23 Cipher Mining reports Q1 adjusted EPS 3c, consensus (2c) 03/14/23 Cipher Mining reports FY22 adjusted EPS (26c) vs (4c) last year
Hot Stocks
The company said,…
The company said, "The Company thanks Dr. Richard Bryce, MBCHB, MRCGP, MFPM, Rain's CMO, for his tremendous efforts with the MANTRA study, and notes a planned transition from CMO to an ongoing advisory role, with Rain's cofounder, President and chief scientific officer, Dr. Robert Doebele, MD, PhD, to assume the role of CMO."
Show Hide Related Items >> <<
05/30/23 Rain Oncology provides update, outlines priorities for milademetan program 05/22/23 Rain Oncology Phase 3 MANTRA trial did not meet primary endpoint 01/23/23 Rain Oncology announces publication of Phase 1 data of milademetan 12/29/22 Rain Therapeutics announces name change to Rain Oncology 05/23/23 H.C. Wainwright Rain Oncology downgraded to Neutral from Buy at H.C. Wainwright 05/23/23 Oppenheimer Rain Oncology downgraded to Perform on Phase 3 failure at Oppenheimer 05/23/23 Citi Rain Oncology downgraded to Neutral from Buy at Citi 05/22/23 Oppenheimer Rain Oncology downgraded to Perform from Outperform at Oppenheimer 05/11/23 Rain Oncology reports Q1 EPS (56c), consensus (61c) 03/09/23 Rain Oncology reports Q4 EPS (70c), consensus (56c) 05/23/23 What You Missed On Wall Street On Tuesday 05/23/23 What You Missed On Wall Street This Morning 05/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/22/23 What You Missed On Wall Street On Monday
Hot Stocks
Rain Oncology announced…
Rain Oncology announced an update to its clinical strategy for milademetan, its small molecule inhibitor of the MDM2-p53 complex, to optimize Company resources. The Company is focused on reducing its cash burn with the expectation to extend cash runway to year-end 2026. "We are working diligently, as additional information continues to come in, to analyze and understand the outcomes in the Phase 3 MANTRA study in DD LPS," said Avanish Vellanki, co-founder and chief executive officer of Rain. "It is imperative we understand those outcomes before allocating further capital to the milademetan program, with corporate expenses to be greatly reduced to maximize optionality for Rain. In the near-term, Rain plans to suspend enrollment in our Phase 2 MANTRA-2 basket trial and terminate plans to initiate the planned Phase 1/2 MANTRA-4 combination trial." Strategic Update Summary: Continue evaluation of the totality of the pivotal Phase 3 MANTRA data; Planned data presentation at a medical conference in 4Q 2023; Suspend enrollment of additional patients into the MANTRA-2 MDM2 amplified basket study; Planned MANTRA-2 clinical update at a medical conference in 4Q 2023; Terminate plans for the MANTRA-4 clinical study in patients with CDKN2A-loss, p53 wildtype advanced solid tumors; Evaluate avenues to enhance the pipeline through precision oncology program acquisition; Streamline internal resources to execute on realigned strategy; Reducing full-time employees by approximately 65%, combined with careful workforce management, including employee attrition; Year-end 2023 cash guidance of $75-$80 million, and cash runway to year-end 2026
Show Hide Related Items >> <<
05/22/23 Rain Oncology Phase 3 MANTRA trial did not meet primary endpoint 01/23/23 Rain Oncology announces publication of Phase 1 data of milademetan 12/29/22 Rain Therapeutics announces name change to Rain Oncology 05/23/23 H.C. Wainwright Rain Oncology downgraded to Neutral from Buy at H.C. Wainwright 05/23/23 Oppenheimer Rain Oncology downgraded to Perform on Phase 3 failure at Oppenheimer 05/23/23 Citi Rain Oncology downgraded to Neutral from Buy at Citi 05/22/23 Oppenheimer Rain Oncology downgraded to Perform from Outperform at Oppenheimer 05/11/23 Rain Oncology reports Q1 EPS (56c), consensus (61c) 03/09/23 Rain Oncology reports Q4 EPS (70c), consensus (56c) 05/23/23 What You Missed On Wall Street On Tuesday 05/23/23 What You Missed On Wall Street This Morning 05/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/22/23 What You Missed On Wall Street On Monday
Over a week ago
Downgrade
EF Hutton downgraded…
EF Hutton downgraded Apexigen (APGN) to Hold from Buy with a 64c price target after Pyxis Oncology (PYXS) announced a definitive agreement to acquire Apexigen in an all-stock transaction for an implied value of 64c per Apexigen share. The firm assumes there will be no other bidder for Apexigen at this time.
Show Hide Related Items >> <<
05/24/23 Pyxis Oncology to acquire Apexigen in all-stock transaction for EV $16M 02/27/23 Apexigen announces review of strategic alternatives, 55% workforce reduction 01/19/23 Apexigen announces new data evaluating agonist antibody sotigalimab for CD40 03/10/23 Brookline Apexigen downgraded to Hold from Buy at Brookline 02/27/23 Roth MKM Apexigen downgraded to Neutral from Buy at Roth MKM 01/24/23 Roth MKM Apexigen resumed with a Buy at Roth Capital 01/04/23 EF Hutton Apexigen initiated with a Buy at EF Hutton
Hot Stocks
Pyxis Oncology (PYXS) and…
Pyxis Oncology (PYXS) and Apexigen (APGN) announced a definitive agreement by which Pyxis Oncology will acquire Apexigen in an all-stock transaction for an implied value of 64c per Apexigen share. For each share of Apexigen, Pyxis Oncology will issue 0.1725 shares of its common stock, par value $0.001 per share, for a total enterprise value of approximately $16M. Upon closing of this business combination, Apexigen will become a wholly owned subsidiary of Pyxis Oncology. Pyxis Oncology's current stockholders will beneficially own approximately 90% of the combined company and Apexigen's stockholders will beneficially own approximately 10% of the combined company. The definitive merger agreement has been approved by the Boards of Directors of each company and is anticipated to close by mid-2023, subject to the satisfaction or waiver of customary closing conditions, including approval by the stockholders of Apexigen and the effectiveness of a registration statement on Form S-4 to register the shares of Pyxis Oncology common stock to be issued in connection with the transaction.
Show Hide Related Items >> <<
05/11/23 Pyxis Oncology expects cash to fund operations into 1H25 05/03/23 Pyxis Oncology's treatment of pancreatic cancer granted FDA orphan designation 03/21/23 Pyxis Oncology discloses $5M purchase of common stock by Pfizer 03/16/23 Pyxis Oncology announces dosing of first subject in Phase 1 trial of PYX-201 02/27/23 Apexigen announces review of strategic alternatives, 55% workforce reduction 01/19/23 Apexigen announces new data evaluating agonist antibody sotigalimab for CD40 03/10/23 Brookline Apexigen downgraded to Hold from Buy at Brookline 02/27/23 Roth MKM Apexigen downgraded to Neutral from Buy at Roth MKM 01/24/23 Roth MKM Apexigen resumed with a Buy at Roth Capital 01/04/23 EF Hutton Apexigen initiated with a Buy at EF Hutton 05/11/23 Pyxis Oncology reports Q1 EPS (54c), consensus (90c) 04/12/23 Fifteen new option listings on April 12th
On The Fly
Get caught up quickly on…
Show Hide Related Items >> <<
05/22/23 Zoom Video says Zoom Phone surpassed 10% of revenue in Q1 05/22/23 Zoom Video reports 3,580 customers contributing more than $100,000 in Q1 05/16/23 Zoom Video CFO Steckelberg sells $206K in company shares 05/16/23 Zoom Video partners with Anthropic to expand federated approach to AI 05/23/23 Yelp sees headcount about flat by end of the year 05/23/23 Yelp says new AI uses have been positive for customer experience 05/23/23 Yelp says it had 'tremendous amount' of services traffic in Q1 05/23/23 Yelp rises 10.5% 05/23/23 Williams-Sonoma rises 4.7% 03/16/23 Williams-Sonoma increases quarterly dividend, stock buyback program 01/30/23 Williams-Sonoma appoints Marta Benson as CEO, Pottery Barn Brands WH Wyndham Hotels & Resorts 05/23/23 Wyndham Hotels & Resorts trading resumes 05/23/23 Wyndham Hotels & Resorts trading halted, volatility trading pause 04/10/23 Nasdaq tells Virgin Orbit trading of common stock to be suspended on April 13 04/10/23 Nasdaq tells Virgin Orbit common stock to be suspended on April 13 04/04/23 Virgin Orbit commences Chapter 11 proceeding to effectuate sale 03/30/23 Virgin Orbit unable to secure funding, to cease operations, lay off 85% of staff 05/23/23 Vipshop CFO David Cui to resign, Mark Wang to succeed 03/31/23 Vipshop announces $500M share repurchase program 01/30/23 Vipshop falls -8.5% 12/27/22 China stocks rising with borders set to reopen on January 8 05/16/23 Tesla CEO says we adjust pricing to match demand based on incoming daily data 05/16/23 Tesla CEO says there's some 'good logic' to starting advertising to reach people 05/16/23 Tesla CEO says millions of its current cars can achieve FSD with software update 05/16/23 Tesla's Musk says not considering stepping down as CEO 05/22/23 Tegna entitled to receive a termination fee of $136M from Standard General 05/22/23 Tegna terminates merger agreement with Standard General 05/22/23 Tegna raises dividend 20% to 11.35c 05/22/23 Tegna announces $300M ASR agreement with JPMorgan Chase Bank 05/23/23 Shutterstock to acquire GIPHY from Meta Platforms for $53M 05/23/23 Shutterstock to acquire GIPHY from Meta Platforms for $53M 04/19/23 Shutterstock enters exclusive deal with Vecteezy 03/21/23 Shutterstock, Nvidia partner to build AI foundation models RYAN Ryan Specialty Group 05/23/23 Ryan Specialty Group to acquire Socius Insurance, terms not disclosed 03/15/23 Ryan Specialty Group CEO buys $7.78M in common stock 01/03/23 Ryan Specialty Group completes acquisition of Griffin Underwriting Services 12/12/22 Ryan Specialty Group to acquire assets of Griffin Underwriting Services 05/22/23 Rain Oncology Phase 3 MANTRA trial did not meet primary endpoint 01/23/23 Rain Oncology announces publication of Phase 1 data of milademetan 12/29/22 Rain Therapeutics announces name change to Rain Oncology 05/23/23 Perion Network falls 5% in pre-market trading following Spruce Point short call 05/23/23 Spruce Point issues short report on Perion Network, sees up to 40% downside risk 05/23/23 Spruce Point issues short report on Perion Network 02/08/23 Perion Network announces six-month CEO transition period $22.68 / +2.635 (+13.15%)
04/18/23 Myriad, Intermountain Precision now offer solid tumor testing in all states 04/12/23 Myriad Genetics, SimonMed Imaging collaborate to advance precision medicine 03/02/23 Myriad Genetics, Illumina expand partnership for HRD testing access 03/02/23 Illumina and Myriad Genetics partner for HRD testing in the U.S. 05/22/23 Meta Platforms says Bombyx being licensed for product development 05/22/23 WhatsApp introduces 'Edit' feature for sent messages $206.67 / +3.585 (+1.77%)
05/23/23 Lowe's says Q2 performing 'at our current guidance' 05/23/23 Lowe's reports Q1 gross margin 33.7%, down 35 bps y/y 05/23/23 Lowe's seeing increased demand in paint, especially from Pro's 05/23/23 Lowe's 'optimistic' customers will re-engage with projects as weather improves 05/22/23 Lilium signs agreement with Air-Dynamic to serve Switzerland and Italy 05/11/23 Lilium, FlightSafety International sign flight simulator, training agreement 05/04/23 Lilium Jet enters powered test campaign at DNW facility 05/02/23 Lilium up 20% after announcing capital raise 05/19/23 Intercept 'disappointed' in outcome of FDA's advisory meeting 05/19/23 Intercept announces outcome of FDA meeting to review NDA for obeticholic acid 05/19/23 FDA panel votes 12-2 against Intercept's pre-cirrhotic fibrosis treatment 05/19/23 Intercept announces Nasdaq halt of trading, FDA advisory committee meeting IART Integra LifeSciences $40.52 / -10.21 (-20.13%)
05/23/23 Integra LifeSciences falls 15% after product recall, Q2 guidance cut 05/23/23 Integra LifeSciences voluntary recalls all products made in Boston plant 01/25/23 Integra LifeSciences confirms Carrie Anderson to step down as CFO 01/25/23 Campbell Soup names Carrie Anderson as new CFO 05/23/23 Dick's Sporting backs FY23 CapEx view $670M-$720M on gross basis 05/23/23 Dick's Sporting CEO says 'we are very pleased with our first quarter results' 05/19/23 Dick's Sporting falls -6.2% 05/04/23 SidelineSwap secures investment from eBay Ventures 05/22/23 Chevron to acquire PDC Energy in $6.3B all-stock transaction 05/15/23 Berkshire Hathaway takes stake in Capital One, exits RH 05/15/23 Tiger Management adds Nvidia in Q1, sells out of Toast and Chevron 04/28/23 Chevron expects to repurchase $4.375B in shares in Q2 $113.38 / -5.395 (-4.54%)
05/23/23 Wyndham Hotels up 11% tp $73.17 after WSJ report of Choice interest 05/23/23 Choice Hotels falls 4% following WSJ report of Wyndham interest 03/01/23 Choice Hotels raises quarterly dividend 21% to 28.75c from 23.75c per share 02/15/23 Choice Hotels sees FY23 adjusted EBITDA $520M-$540M 05/23/23 BJ's Wholesale falls -6.9% 05/23/23 BJ's Wholesale falls -6.2% 05/23/23 BJ's Wholesale falls -6.9% 05/23/23 BJ's Wholesale reports Q1 digitally enabled comparable sales growth 19.0% y/y 05/18/23 Alibaba comments on spinoffs, capital raisings 05/18/23 Alibaba: Board has approved full spinoff of Cloud Intelligence Group 05/15/23 Third Point buys Alibaba, cuts AIG in Q1 05/15/23 Alibaba says SEC completed review of fiscal 2022 annual report $2,463.18 / -157.905 (-6.02%)
05/23/23 AutoZone reports inventory up 7.4% y/y 02/28/23 AutoZone reports inventory up 13.9% y/y 02/14/23 Tiger Global boosts stakes in Visa, Mastercard, reduces position in Microsoft 04/18/23 Broadcom announces delivery of Jericho3-AI 05/23/23 Amazon opens pre-orders for Fire Max 11 tablet 05/18/23 AWS to invest $12.7B into cloud infrastructure in India 05/17/23 Amazon announces launch of new lineup of Echo products 05/16/23 Latch says Ring-creator Jamie Siminoff to take over as CEO later this year $108.13 / +0.135 (+0.13%)
05/23/23 AMD announces new lineup of AMD Ryzen, Athlon 7020 C-Series processors 05/04/23 OverActive Media signs sponsorship agreements with AMD, LG UltraGear 04/25/23 AMD introduces Ryzen Z1 series processors 04/24/23 Analog Devices appoints Alan Lee as CTO 05/23/23 Broadcom up 2% after Apple announces 'multibillion-dollar' supply deal 05/23/23 Broadcom reports two separate multi-year statements of work with Apple 05/23/23 Apple reports 'multibillion-dollar' deal with Broadcom for U.S.-made components 05/22/23 United Airlines to support Live Activities for iPhone 05/23/23 BofA Broadcom price target raised to $800 from $725 at BofA 05/22/23 Loop Capital Loop downgrades Apple on 'material downside risk' to guidance 05/22/23 Loop Capital Apple downgraded to Hold from Buy at Loop Capital 04/27/23 Piper Sandler VMware price target lowered to $125 from $142.50 at Piper Sandler 04/12/23 Benchmark Broadcom initiated with a Buy at Benchmark 03/03/23 OTR Global Qualcomm displacing Broadcom for S23 components, says OTR Global 04/26/23 Truist Shutterstock price target raised to $88 from $86 at Truist 02/10/23 Truist Shutterstock price target raised to $86 from $70 at Truist 11/28/22 JMP Securities Shutterstock downgraded to Market Perform from Outperform at JMP Securities 10/26/22 Needham Shutterstock price target lowered to $62 from $70 at Needham 05/23/23 Piper Sandler Meta's AI initiatives could drive revenue recapture, says Piper Sandler 05/23/23 Citi Citi sees minimal risk to Meta Platforms after E.U. data fine 05/22/23 Evercore ISI Meta, Spotify, Zillow removed from 'Tactical Outperform' list at Evercore ISI 05/19/23 Roth MKM Meta Platforms' capex may decline in 2023-2024, says Roth MKM 05/12/23 Barrington Tegna may see pressure on formal deal termination, says Barrington 04/12/23 Benchmark Tegna price target lowered to $22 from $24 at Benchmark 03/28/23 Wells Fargo Tegna price target lowered to $18 from $20 at Wells Fargo 02/28/23 Guggenheim Tegna price target lowered to $22 from $24 at Guggenheim 05/23/23 Piper Sandler Zoom Video price target lowered to $76 from $78 at Piper Sandler 05/23/23 Evercore ISI Zoom Video price target lowered to $75 from $85 at Evercore ISI 05/23/23 Needham Needham stay neutral on Zoom Video pending more visibility on Enterprise growth 05/23/23 RBC Capital Zoom Video Online segment stabilizing but Enterprize slowing, says RBC Capital $206.67 / +3.585 (+1.77%)
05/24/23 Barclays Lowe's price target lowered to $212 from $215 at Barclays 05/23/23 DA Davidson Lowe's comps beats Home Depot for first time since Q4 of 2020, says DA Davidson 05/16/23 Mizuho Stanley Black & Decker has negative read from Home Depot report, says Mizuho 05/12/23 Baird Lowe's price target lowered to $225 from $235 at Baird 05/24/23 Mizuho Chevron price target raised to $202 from $196 at Mizuho 05/24/23 Mizuho PDC Energy downgraded to Neutral from Buy at Mizuho 05/23/23 Morgan Stanley Chevron price target raised to $198 from $192 at Morgan Stanley 05/23/23 HSBC Chevron upgraded to Buy from Hold at HSBC $22.68 / +2.635 (+13.15%)
05/23/23 Goldman Sachs Myriad Genetics upgraded to Buy from Sell at Goldman Sachs 03/06/23 Stephens Myriad Genetics price target raised to $24 from $17 at Stephens 01/18/23 Raymond James Myriad Genetics upgraded to Outperform from Market Perform at Raymond James 01/18/23 Raymond James Myriad Genetics upgraded to Outperform from Market Perform at Raymond James 05/23/23 H.C. Wainwright Rain Oncology downgraded to Neutral from Buy at H.C. Wainwright 05/23/23 Oppenheimer Rain Oncology downgraded to Perform on Phase 3 failure at Oppenheimer 05/23/23 Citi Rain Oncology downgraded to Neutral from Buy at Citi 05/22/23 Oppenheimer Rain Oncology downgraded to Perform from Outperform at Oppenheimer 05/23/23 BofA Intercept price target lowered to $14 from $17 at BofA 05/23/23 Canaccord Intercept price target lowered to $12 from $26 at Canaccord 05/23/23 Needham Needham downgrades Intercept, says NASH approval 'highly unlikely' 05/23/23 Needham Intercept downgraded to Hold from Buy at Needham IART Integra LifeSciences $40.52 / -10.21 (-20.13%)
05/24/23 JPMorgan Integra LifeSciences downgraded to Underweight from Neutral at JPMorgan 05/23/23 BTIG Organogenesis upgraded to Buy from Neutral at BTIG 05/23/23 Citi Citi downgrades Integra to Sell, sees further guidance cuts 05/23/23 Citi Integra LifeSciences downgraded to Sell from Neutral at Citi 03/17/23 Canaccord Virgin Orbit rating, target put under review at Canaccord after operations halt 01/11/23 Canaccord Virgin Orbit price target lowered to $6 from $12 10/11/22 Credit Suisse Virgin Orbit initiated with Underperform on elevated cash burn at Credit Suisse 10/11/22 Credit Suisse Virgin Orbit initiated with an Underperform at Credit Suisse 05/23/23 Susquehanna Alibaba price target lowered to $160 from $175 at Susquehanna 05/19/23 Baird Alibaba price target lowered to $115 from $120 at Baird 05/19/23 BofA Alibaba price target lowered to $132 from $144 at BofA 05/19/23 Benchmark Alibaba capital management plan a positive catalyst, says Benchmark $113.38 / -5.395 (-4.54%)
05/12/23 Morgan Stanley Choice Hotels price target raised to $134 from $130 at Morgan Stanley 05/12/23 Baird Choice Hotels price target raised to $135 from $134 at Baird 05/10/23 Barclays Choice Hotels price target lowered to $119 from $120 at Barclays 03/24/23 Truist Choice Hotels price target raised to $132 from $120 at Truist WH Wyndham Hotels & Resorts 04/28/23 Barclays Wyndham Hotels & Resorts shares look oversold, says Barclays 04/27/23 Stifel Wyndham Hotels & Resorts price target lowered to $81 from $87 at Stifel 04/27/23 Oppenheimer Wyndham Hotels & Resorts price target lowered to $90 from $100 at Oppenheimer 04/21/23 Barclays Wyndham Hotels & Resorts price target lowered to $88 from $89 at Barclays 05/23/23 Mizuho Mizuho ups Amazon target, names a top pick for second half on AI 05/08/23 Loop Capital Amazon.com AWS slowdown transitory, says Loop Capital 05/03/23 Roth MKM Veritone price target lowered to $8 from $11 at Roth MKM 05/03/23 Oppenheimer Microsoft's differentiated AI strategy boosts secular growth, says Oppenheimer 05/05/23 Barclays Yelp price target lowered to $26 from $30 at Barclays 02/13/23 Wells Fargo Yelp price target raised to $39 from $31 at Wells Fargo 12/20/22 JPMorgan Yelp downgraded to Underweight from Neutral at JPMorgan 10/10/22 Morgan Stanley Yelp price target raised to $35 from $33 at Morgan Stanley 03/14/23 Citi Lilium initiated with a Neutral at Citi 12/07/22 Piper Sandler Lilium price target lowered to $7 from $9 at Piper Sandler 12/07/22 Barclays Lilium downgraded to Underweight from Equal Weight at Barclays 11/15/22 Barclays Lilium price target lowered to $2 from $5 at Barclays $108.13 / +0.135 (+0.13%)
05/23/23 BofA AMD price target raised to $120 from $105 at BofA 05/19/23 Cleveland Research AMD Q2, Q3 estimates trimmed at Cleveland Research 05/05/23 Deutsche Bank Bloomberg correction incremental negative for AMD, says Deutsche Bank 05/03/23 Truist AMD price target raised to $84 from $79 at Truist 05/04/23 Lake Street Perion Network price target raised to $40 from $38 at Lake Street 05/04/23 Oppenheimer Perion Network price target raised to $42 from $37 at Oppenheimer 04/24/23 Stifel Perion Network downgraded to Hold from Buy at Stifel 03/22/23 Needham Perion Network price target raised to $42 from $37 at Needham RYAN Ryan Specialty Group 05/05/23 Wells Fargo Ryan Specialty Group price target raised to $50 from $49 at Wells Fargo 04/18/23 Citi Ryan Specialty Group price target raised to $45 from $44 at Citi 02/21/23 Autonomous Ryan Specialty Group initiated with an Underperform at Autonomous 01/19/23 BMO Capital Ryan Specialty Group initiated with an Outperform at BMO Capital 05/24/23 TD Cowen Dick's Sporting price target raised to $171 from $160 at TD Cowen 05/24/23 Wells Fargo Dick's Sporting price target lowered to $140 from $146 at Wells Fargo 05/24/23 Citi Dick's Sporting price target lowered to $135 from $144 at Citi 05/23/23 Baird Dick's Sporting saw solid comps, firm margins in Q1, says Baird $2,463.18 / -157.905 (-6.02%)
05/24/23 JPMorgan AutoZone should be bought on recent pullback, says JPMorgan 05/23/23 Goldman Sachs AutoZone price target lowered to $2,840 from $2,899 at Goldman Sachs 05/22/23 Wedbush AutoZone price target raised to $2,750 from $2,600 at Wedbush 05/17/23 Citi AutoZone price target raised to $3,125 from $2,782 at Citi 05/24/23 Benchmark Vipshop price target raised to $19 from $15 at Benchmark 05/24/23 UBS Vipshop price target raised to $18.50 from $18.00 at UBS 05/24/23 HSBC Vipshop price target raised to $14.40 from $12.50 at HSBC 05/23/23 BofA Vipshop price target raised to $17.80 from $15.20 at BofA 05/24/23 Barclays Williams-Sonoma price target lowered to $126 from $135 at Barclays 05/18/23 Citi Williams-Sonoma price target lowered to $123 from $127 at Citi 05/17/23 JPMorgan JPMorgan sees risk for Williams-Sonoma on 'deteriorating backdrop' 03/17/23 RBC Capital Williams-Sonoma price target lowered to $143 from $151 at RBC Capital 05/24/23 JPMorgan BJ's Wholesale price target lowered to $62 from $65 at JPMorgan 05/24/23 Citi BJ's Wholesale price target lowered to $74 from $83 at Citi 05/23/23 BofA BJ's Wholesale price target lowered to $85 from $87 at BofA 05/12/23 JPMorgan BJ's Wholesale price target lowered to $65 from $67 at JPMorgan 05/23/23 Oppenheimer Shares may move higher near-term as Tesla outperforms peers, says Oppenheimer 05/18/23 Wedbush Wedbush says Tesla/Musk strategy feels solid as investors focus on price wars 05/17/23 Wedbush Potential advertising campaign 'a major positive' for Tesla, says Wedbush 05/17/23 Bernstein 2024 could be even more challenging for Tesla, says Bernstein 05/22/23 Zoom Video sees FY24 EPS $4.25-$4.31, consensus $4.22 05/22/23 Zoom Video sees Q2 EPS $1.04-$1.06, consensus $1.05 05/22/23 Zoom Video reports Q1 EPS $1.16, consensus 99c 05/22/23 Notable companies reporting after market close 05/04/23 Yelp raises FY23 revenue view to $1.295B-$1.315B, consensus $1.3B 05/04/23 Yelp reports Q1 EPS (2c), consensus (5c) 02/09/23 Yelp sees FY23 revenue $1.29B-$1.31B, consensus $1.29B 02/09/23 Yelp reports Q4 EPS 28c, consensus 28c 05/23/23 Williams-Sonoma backs FY23 revenue view down 3% to up 3%, consensus $8.33B 05/23/23 Williams-Sonoma reports Q1 EPS $2.64, consensus $2.37 WH Wyndham Hotels & Resorts 04/26/23 Wyndham Hotels & Resorts raises FY23 adjusted EPS view to $3.92-$4.06 04/26/23 Wyndham Hotels & Resorts reports Q1 EPS 77c, consensus 80c 02/15/23 Wyndham Hotels & Resorts sees FY23 adjusted EPS $3.84-$3.98, consensus $3.92 02/15/23 Wyndham Hotels & Resorts reports Q4 adjusted EPS 72c, consensus 62c 05/23/23 Vipshop sees Q2 revenue up 10%-15%, consensus 3.79B 05/23/23 Vipshop reports Q1 EPS 46c, consensus 37c 02/23/23 Vipshop sees Q1 revenue flat to up 5%, consensus $3.6B 02/23/23 Vipshop reports Q4 EPS 53c, consensus 47c 04/19/23 Tesla reports Q1 EPS 85c, consensus 85c 04/19/23 Notable companies reporting after market close 03/02/23 Aehr Test Systems reiterates annual guidance, comments on Tesla statements 01/25/23 Tesla reports Q4 EPS $1.19, consensus $1.13 05/10/23 Tegna reports Q1 EPS 47c, consensus 47c 02/27/23 Tegna reports Q4 EPS 98c, consensus $1.13 04/25/23 Shutterstock sees FY23 adjusted EPS $4.00-$4.10, consensus $4.03 04/25/23 Shutterstock reports Q1 adjusted EPS $1.29, consensus $1.07 02/09/23 Shutterstock sees 2023 adjuted EPS $3.90-$4.05, consensus $3.50 02/09/23 Shutterstock reports Q4 adjusted EPS $1.05, consensus 95c RYAN Ryan Specialty Group 05/04/23 Ryan Specialty narrows FY23 revenue growth view to 10.5%-13% from 10%-13% 05/04/23 Ryan Specialty Group reports Q1 adjusted EPS 26c, consensus 25c 02/28/23 Ryan Specialty Group sees FY23 organic revenue growth 10%-13%, consensus $2B 02/28/23 Ryan Specialty Group reports Q4 adjusted EPS 27c, consensus 26c 05/11/23 Rain Oncology reports Q1 EPS (56c), consensus (61c) 03/09/23 Rain Oncology reports Q4 EPS (70c), consensus (56c) 05/03/23 Perion Network raises FY23 revenue view to $725M-$745M from $720M-$740M 05/03/23 Perion Network reports Q1 adjusted EPS 60c, consensus 43c 02/08/23 Perion Network sees FY23 revenue $720M-$740M, consensus $730.03M 02/08/23 Perion Network reports Q4 adjusted EPS 90c, consensus 59c $22.68 / +2.635 (+13.15%)
05/03/23 Myriad Genetics narrows FY 23 EPS range to (36c) -(24c) , consensus (32c) 05/03/23 Myriad Genetics reports Q1 EPS (21c), consensus (19c) 02/28/23 Myriad Genetics sees FY23 (40c)-(20c), consensus (30c) 02/28/23 Myriad Genetics sees Q1 EPS (20c)-(18c), consensus (10c) 04/26/23 Meta Platforms sees Q2 revenue $29.5B-$32B, consensus $29.48B 04/26/23 Meta Platforms reports Q1 EPS $2.20, consensus $2.53 04/26/23 Notable companies reporting after market close $206.67 / +3.585 (+1.77%)
05/23/23 Lowe's sees $400M headwind to Q2 sales 05/23/23 Lowe's cuts FY23 EPS view to $13.20-$13.60 from 13.60-$14.00, consensus $13.73 05/23/23 Lowe's reports Q1 adjusted EPS $3.67, consensus $3.44 05/22/23 Notable companies reporting before tomorrow's open 04/27/23 Intercept reports Q1 EPS (77c), consensus (65c) 03/02/23 Intercept reports Q4 EPS (50c), consensus (16c) 01/11/23 Intercept sees FY22 net sales of $343M, up 10% y/y IART Integra LifeSciences $40.52 / -10.21 (-20.13%)
05/23/23 Integra LifeSciences sees Q2 adjusted EPS 55c-59c, consensus 77c 04/26/23 Integra LifeSciences sees Q2 adjusted EPS 75c-79c, consensus 85c 04/26/23 Integra LifeSciences backs FY23 adjusted EPS view $3.43-$3.51, consensus $3.48 04/26/23 Integra LifeSciences reports Q1 adjusted EPS 74c, consensus 74c 05/23/23 Dick's Sporting backs FY23 EPS view $12.90-$13.80, consensus $13.44 05/23/23 Dick's Sporting reports Q1 adjusted EPS $3.40, consensus $3.18 04/28/23 Chevron reports Q1 adjusted EPS $3.55, consensus $3.41 04/27/23 Notable companies reporting before tomorrow's open 01/27/23 Chevron reports Q4 adjusted EPS $4.09, consensus $4.38 $113.38 / -5.395 (-4.54%)
05/09/23 Choice Hotels backs FY23 adjusted EPS view $5.70-$5.90, consensus $5.74 05/09/23 Choice Hotels reports Q1 EPS $1.02, consensus $1.01 02/15/23 Choice Hotels sees Q1 net income $245M-$265M 02/15/23 Choice Hotels reports Q4 adjusted EPS $1.26, consensus $1.05 05/23/23 BJ's Wholesale backs FY23 guidance 05/23/23 BJ's Wholesale reports Q1 adjusted EPS 85c, consensus 85c 03/09/23 BJ's Wholesale provides long-term financial outlook 03/09/23 BJ's Wholesale sees FY23 EPS 'approximately flat y/y,' consensus $3.85 05/18/23 Alibaba reports Q4 EPS $1.56, consensus $1.35 05/17/23 Notable companies reporting before tomorrow's open 02/23/23 Alibaba reports Q3 adjusted EPS $2.79, consensus $2.37 $2,463.18 / -157.905 (-6.02%)
05/23/23 AutoZone reports Q3 EPS $34.12, consensus $31.42 02/28/23 AutoZone reports Q2 EPS $24.64, consensus $21.91 03/02/23 Broadcom sees Q2 revenue approximately $8.7B, consensus $8.59B 03/02/23 Broadcom reports Q1 adjusted EPS $10.33, consensus $10.10 03/02/23 VMware reports Q4 EPS $2.13, consensus $1.92 03/02/23 Notable companies reporting after market close 04/27/23 Amazon sees Q2 revenue $127B-$133B, consensus $129.83B 04/27/23 Amazon reports Q1 EPS 31c with Rivian loss, consensus 21c 04/27/23 Notable companies reporting after market close 02/02/23 Amazon sees Q1 revenue $121B-$126B, consensus $125.11B $108.13 / +0.135 (+0.13%)
05/02/23 AMD sees Q2 revenue $5.3B +/- $300M, consensus $5.49B 05/02/23 AMD reports Q1 EPS 60c, consensus 56c 05/02/23 Notable companies reporting after market close 05/01/23 Notable companies reporting before tomorrow's open 05/21/23 Fly Intel: Top five weekend stock stories 05/04/23 Apple sees Q3 revenue growth 'similar' to Q2, consensus $84.71B 05/04/23 Apple sees Q3 revenue 'similar' to Q2, consensus $84.71B 05/04/23 Apple reports Q2 EPS $1.52, consensus $1.43
On The Fly
Get caught up quickly on…
Show Hide Related Items >> <<
05/22/23 Zoom Video says Zoom Phone surpassed 10% of revenue in Q1 05/22/23 Zoom Video reports 3,580 customers contributing more than $100,000 in Q1 05/16/23 Zoom Video CFO Steckelberg sells $206K in company shares 05/16/23 Zoom Video partners with Anthropic to expand federated approach to AI 05/23/23 Yelp rises 10.5% 05/23/23 Yelp rises 9.6% 05/23/23 TCS Capital calls on Yelp board to begin exploring strategic alternatives 05/22/23 Yelp officer Orr sells $258K in company shares $114.79 / +2.675 (+2.39%)
05/23/23 Williams-Sonoma rises 4.7% 03/16/23 Williams-Sonoma increases quarterly dividend, stock buyback program 01/30/23 Williams-Sonoma appoints Marta Benson as CEO, Pottery Barn Brands 05/23/23 Vipshop CFO David Cui to resign, Mark Wang to succeed 03/31/23 Vipshop announces $500M share repurchase program 01/30/23 Vipshop falls -8.5% 12/27/22 China stocks rising with borders set to reopen on January 8 05/22/23 Tegna entitled to receive a termination fee of $136M from Standard General 05/22/23 Tegna terminates merger agreement with Standard General 05/22/23 Tegna raises dividend 20% to 11.35c 05/22/23 Tegna announces $300M ASR agreement with JPMorgan Chase Bank 05/23/23 Shutterstock to acquire GIPHY from Meta Platforms for $53M 05/23/23 Shutterstock to acquire GIPHY from Meta Platforms for $53M 04/19/23 Shutterstock enters exclusive deal with Vecteezy 03/21/23 Shutterstock, Nvidia partner to build AI foundation models RYAN Ryan Specialty Group 03/15/23 Ryan Specialty Group CEO buys $7.78M in common stock 01/03/23 Ryan Specialty Group completes acquisition of Griffin Underwriting Services 12/12/22 Ryan Specialty Group to acquire assets of Griffin Underwriting Services 05/22/23 Rain Oncology Phase 3 MANTRA trial did not meet primary endpoint 01/23/23 Rain Oncology announces publication of Phase 1 data of milademetan 12/29/22 Rain Therapeutics announces name change to Rain Oncology 05/23/23 Perion Network falls 5% in pre-market trading following Spruce Point short call 05/23/23 Spruce Point issues short report on Perion Network, sees up to 40% downside risk 05/23/23 Spruce Point issues short report on Perion Network 02/08/23 Perion Network announces six-month CEO transition period $23.13 / +3.085 (+15.39%)
04/18/23 Myriad, Intermountain Precision now offer solid tumor testing in all states 04/12/23 Myriad Genetics, SimonMed Imaging collaborate to advance precision medicine 03/02/23 Myriad Genetics, Illumina expand partnership for HRD testing access 03/02/23 Illumina and Myriad Genetics partner for HRD testing in the U.S. 04/13/23 Microvast announces appointment of Isida Tushe as general counsel 03/15/23 Microvast selected by MAFI & TREPEL as battery supplier for EV tractors 12/07/22 Microvast secures contract to supply BESS to U.S. customer 05/22/23 Meta Platforms says Bombyx being licensed for product development 05/22/23 WhatsApp introduces 'Edit' feature for sent messages 05/23/23 Lowe's says Q2 performing 'at our current guidance' 05/23/23 Lowe's reports Q1 gross margin 33.7%, down 35 bps y/y 05/23/23 Lowe's seeing increased demand in paint, especially from Pro's 05/23/23 Lowe's 'optimistic' customers will re-engage with projects as weather improves 05/22/23 Lilium signs agreement with Air-Dynamic to serve Switzerland and Italy 05/11/23 Lilium, FlightSafety International sign flight simulator, training agreement 05/04/23 Lilium Jet enters powered test campaign at DNW facility 05/02/23 Lilium up 20% after announcing capital raise 05/23/23 Climb Global signs $50M credit facility with JPMorgan Chase 05/22/23 Dimon says 'everybody should be prepared for higher rates from here' 05/22/23 JPMorgan's Dimon says board will decide post-CCAR on dividend 05/19/23 Intercept 'disappointed' in outcome of FDA's advisory meeting 05/19/23 Intercept announces outcome of FDA meeting to review NDA for obeticholic acid 05/19/23 FDA panel votes 12-2 against Intercept's pre-cirrhotic fibrosis treatment 05/19/23 Intercept announces Nasdaq halt of trading, FDA advisory committee meeting IART Integra LifeSciences $43.01 / -7.725 (-15.23%)
05/23/23 Integra LifeSciences falls 15% after product recall, Q2 guidance cut 05/23/23 Integra LifeSciences voluntary recalls all products made in Boston plant 01/25/23 Integra LifeSciences confirms Carrie Anderson to step down as CFO 01/25/23 Campbell Soup names Carrie Anderson as new CFO 05/23/23 Dick's Sporting backs FY23 CapEx view $670M-$720M on gross basis 05/23/23 Dick's Sporting CEO says 'we are very pleased with our first quarter results' 05/19/23 Dick's Sporting falls -6.2% 05/04/23 SidelineSwap secures investment from eBay Ventures 05/15/23 Trian Fund buys GE Healthcare, exits Sysco in Q1 05/14/23 Fly Intel: Top five weekend stock stories 05/10/23 Disney CEO Bob Iger comments on company feud with Gov. Ron DeSantis 05/22/23 Chevron to acquire PDC Energy in $6.3B all-stock transaction 05/15/23 Berkshire Hathaway takes stake in Capital One, exits RH 05/15/23 Tiger Management adds Nvidia in Q1, sells out of Toast and Chevron 04/28/23 Chevron expects to repurchase $4.375B in shares in Q2 05/23/23 BJ's Wholesale falls -6.2% 05/23/23 BJ's Wholesale falls -6.9% 05/23/23 BJ's Wholesale reports Q1 digitally enabled comparable sales growth 19.0% y/y 03/14/23 BJ's Wholesale announces partnership with Simbe 05/18/23 Alibaba comments on spinoffs, capital raisings 05/18/23 Alibaba: Board has approved full spinoff of Cloud Intelligence Group 05/15/23 Third Point buys Alibaba, cuts AIG in Q1 05/15/23 Alibaba says SEC completed review of fiscal 2022 annual report $2,470.00 / -151.08 (-5.76%)
05/23/23 AutoZone reports inventory up 7.4% y/y 02/28/23 AutoZone reports inventory up 13.9% y/y 02/14/23 Tiger Global boosts stakes in Visa, Mastercard, reduces position in Microsoft $695.78 / +18.01 (+2.66%)
05/23/23 Broadcom up 2% after Apple announces 'multibillion-dollar' supply deal 05/23/23 Broadcom reports two separate multi-year statements of work with Apple 05/23/23 Apple reports 'multibillion-dollar' deal with Broadcom for U.S.-made components 04/18/23 Broadcom announces delivery of Jericho3-AI 05/23/23 Amazon opens pre-orders for Fire Max 11 tablet 05/18/23 AWS to invest $12.7B into cloud infrastructure in India 05/17/23 Amazon announces launch of new lineup of Echo products 05/16/23 Latch says Ring-creator Jamie Siminoff to take over as CEO later this year 05/23/23 AMD announces new lineup of AMD Ryzen, Athlon 7020 C-Series processors 05/04/23 OverActive Media signs sponsorship agreements with AMD, LG UltraGear 04/25/23 AMD introduces Ryzen Z1 series processors 04/24/23 Analog Devices appoints Alan Lee as CTO 05/22/23 United Airlines to support Live Activities for iPhone $695.78 / +18.01 (+2.66%)
05/23/23 BofA Broadcom price target raised to $800 from $725 at BofA 04/27/23 Piper Sandler VMware price target lowered to $125 from $142.50 at Piper Sandler 04/12/23 Benchmark Broadcom initiated with a Buy at Benchmark 03/03/23 OTR Global Qualcomm displacing Broadcom for S23 components, says OTR Global 05/22/23 Loop Capital Loop downgrades Apple on 'material downside risk' to guidance 05/22/23 Loop Capital Apple downgraded to Hold from Buy at Loop Capital 04/26/23 Truist Shutterstock price target raised to $88 from $86 at Truist 02/10/23 Truist Shutterstock price target raised to $86 from $70 at Truist 11/28/22 JMP Securities Shutterstock downgraded to Market Perform from Outperform at JMP Securities 10/26/22 Needham Shutterstock price target lowered to $62 from $70 at Needham 05/23/23 Piper Sandler Meta's AI initiatives could drive revenue recapture, says Piper Sandler 05/23/23 Citi Citi sees minimal risk to Meta Platforms after E.U. data fine 05/22/23 Evercore ISI Meta, Spotify, Zillow removed from 'Tactical Outperform' list at Evercore ISI 05/19/23 Roth MKM Meta Platforms' capex may decline in 2023-2024, says Roth MKM 05/12/23 Barrington Tegna may see pressure on formal deal termination, says Barrington 04/12/23 Benchmark Tegna price target lowered to $22 from $24 at Benchmark 03/28/23 Wells Fargo Tegna price target lowered to $18 from $20 at Wells Fargo 02/28/23 Guggenheim Tegna price target lowered to $22 from $24 at Guggenheim 05/23/23 Piper Sandler Zoom Video price target lowered to $76 from $78 at Piper Sandler 05/23/23 Evercore ISI Zoom Video price target lowered to $75 from $85 at Evercore ISI 05/23/23 Needham Needham stay neutral on Zoom Video pending more visibility on Enterprise growth 05/23/23 RBC Capital Zoom Video Online segment stabilizing but Enterprize slowing, says RBC Capital 05/23/23 DA Davidson Lowe's comps beats Home Depot for first time since Q4 of 2020, says DA Davidson 05/16/23 Mizuho Stanley Black & Decker has negative read from Home Depot report, says Mizuho 05/12/23 Baird Lowe's price target lowered to $225 from $235 at Baird 05/10/23 Evercore ISI Lowe's added to 'Tactical Underperform' list at Evercore ISI 05/23/23 Morgan Stanley Chevron price target raised to $198 from $192 at Morgan Stanley 05/23/23 HSBC Chevron upgraded to Buy from Hold at HSBC 05/22/23 KeyBanc KeyBanc expects PDC to trade up toward $70/share after 'surprising' Chevron deal 05/19/23 Mizuho Chevron price target lowered to $196 from $206 at Mizuho $23.13 / +3.085 (+15.39%)
05/23/23 Goldman Sachs Myriad Genetics upgraded to Buy from Sell at Goldman Sachs 03/06/23 Stephens Myriad Genetics price target raised to $24 from $17 at Stephens 01/18/23 Raymond James Myriad Genetics upgraded to Outperform from Market Perform at Raymond James 01/18/23 Raymond James Myriad Genetics upgraded to Outperform from Market Perform at Raymond James 05/23/23 H.C. Wainwright Rain Oncology downgraded to Neutral from Buy at H.C. Wainwright 05/23/23 Oppenheimer Rain Oncology downgraded to Perform on Phase 3 failure at Oppenheimer 05/23/23 Citi Rain Oncology downgraded to Neutral from Buy at Citi 05/22/23 Oppenheimer Rain Oncology downgraded to Perform from Outperform at Oppenheimer 05/23/23 BofA Intercept price target lowered to $14 from $17 at BofA 05/23/23 Canaccord Intercept price target lowered to $12 from $26 at Canaccord 05/23/23 Needham Needham downgrades Intercept, says NASH approval 'highly unlikely' 05/23/23 Needham Intercept downgraded to Hold from Buy at Needham IART Integra LifeSciences $43.01 / -7.725 (-15.23%)
05/23/23 Citi Citi downgrades Integra to Sell, sees further guidance cuts 05/23/23 Citi Integra LifeSciences downgraded to Sell from Neutral at Citi 05/18/23 Truist Integra LifeSciences price target lowered to $54 from $58 at Truist 04/27/23 JMP Securities Integra LifeSciences price target lowered to $65 from $75 at JMP Securities 04/03/23 H.C. Wainwright Microvast initiated with a Buy at H.C. Wainwright 08/18/22 Oppenheimer Oppenheimer starts Microvast with Outperform, $8 price target 08/18/22 Oppenheimer Microvast initiated with an Outperform at Oppenheimer 05/23/23 Susquehanna Alibaba price target lowered to $160 from $175 at Susquehanna 05/19/23 Baird Alibaba price target lowered to $115 from $120 at Baird 05/19/23 BofA Alibaba price target lowered to $132 from $144 at BofA 05/19/23 Benchmark Alibaba capital management plan a positive catalyst, says Benchmark 05/23/23 Morgan Stanley JPMorgan price target raised to $160 from $157 at Morgan Stanley 05/15/23 Jefferies JPMorgan price target lowered to $149 from $152 at Jefferies 05/12/23 Citi State Street, BNY Mellon hurt most from FDIC proposal, says Citi 05/12/23 Evercore ISI JPMorgan price target lowered to $151 from $155 at Evercore ISI 05/08/23 Loop Capital Amazon.com AWS slowdown transitory, says Loop Capital 05/03/23 Roth MKM Veritone price target lowered to $8 from $11 at Roth MKM 05/03/23 Oppenheimer Microsoft's differentiated AI strategy boosts secular growth, says Oppenheimer 05/01/23 Barclays Amazon.com price target lowered to $140 from $150 at Barclays 05/05/23 Barclays Yelp price target lowered to $26 from $30 at Barclays 02/13/23 Wells Fargo Yelp price target raised to $39 from $31 at Wells Fargo 12/20/22 JPMorgan Yelp downgraded to Underweight from Neutral at JPMorgan 10/10/22 Morgan Stanley Yelp price target raised to $35 from $33 at Morgan Stanley 03/14/23 Citi Lilium initiated with a Neutral at Citi 12/07/22 Piper Sandler Lilium price target lowered to $7 from $9 at Piper Sandler 12/07/22 Barclays Lilium downgraded to Underweight from Equal Weight at Barclays 11/15/22 Barclays Lilium price target lowered to $2 from $5 at Barclays RYAN Ryan Specialty Group 05/05/23 Wells Fargo Ryan Specialty Group price target raised to $50 from $49 at Wells Fargo 04/18/23 Citi Ryan Specialty Group price target raised to $45 from $44 at Citi 02/21/23 Autonomous Ryan Specialty Group initiated with an Underperform at Autonomous 01/19/23 BMO Capital Ryan Specialty Group initiated with an Outperform at BMO Capital 05/03/23 Loop Capital Dick's Sporting pricing turning more competitive, says Loop Capital 03/17/23 Loop Capital Academy Sports price target raised to $73 from $65 at Loop Capital 03/14/23 Jefferies Dick's Sporting initiated with a Hold at Jefferies 03/09/23 Loop Capital Dick's Sporting price target raised to $150 from $130 at Loop Capital $2,470.00 / -151.08 (-5.76%)
05/22/23 Wedbush AutoZone price target raised to $2,750 from $2,600 at Wedbush 05/17/23 Citi AutoZone price target raised to $3,125 from $2,782 at Citi 05/15/23 Wells Fargo AutoZone price target raised to $3,000 from $2,850 at Wells Fargo 05/12/23 JPMorgan AutoZone price target raised to $2,975 from $2,750 at JPMorgan 04/03/23 UBS Vipshop price target raised to $18 from $17.50 at UBS 03/29/23 Daiwa Vipshop upgraded to Outperform at Daiwa with negatives 'largely priced in' 03/29/23 Daiwa Vipshop upgraded to Outperform from Hold at Daiwa $114.79 / +2.675 (+2.39%)
05/18/23 Citi Williams-Sonoma price target lowered to $123 from $127 at Citi 05/17/23 JPMorgan JPMorgan sees risk for Williams-Sonoma on 'deteriorating backdrop' 03/17/23 RBC Capital Williams-Sonoma price target lowered to $143 from $151 at RBC Capital 03/17/23 Loop Capital Williams-Sonoma price target lowered to $185 from $205 at Loop Capital 05/12/23 JPMorgan BJ's Wholesale price target lowered to $65 from $67 at JPMorgan 05/10/23 Evercore ISI BJ's Wholesale added to 'Tactical Underperform' list at Evercore ISI 03/10/23 Deutsche Bank BJ's Wholesale price target raised to $93 from $89 at Deutsche Bank 03/10/23 Roth MKM BJ's Wholesale price target raised to $71 from $67 at Roth MKM 05/23/23 BofA AMD price target raised to $120 from $105 at BofA 05/19/23 Cleveland Research AMD Q2, Q3 estimates trimmed at Cleveland Research 05/05/23 Deutsche Bank Bloomberg correction incremental negative for AMD, says Deutsche Bank 05/03/23 Truist AMD price target raised to $84 from $79 at Truist 05/04/23 Lake Street Perion Network price target raised to $40 from $38 at Lake Street 05/04/23 Oppenheimer Perion Network price target raised to $42 from $37 at Oppenheimer 04/24/23 Stifel Perion Network downgraded to Hold from Buy at Stifel 03/22/23 Needham Perion Network price target raised to $42 from $37 at Needham 05/19/23 Macquarie Disney downgraded to Neutral from Outperform at Macquarie 05/12/23 JPMorgan JPMorgan lays out impacts of Disney launching EPSN streaming 05/12/23 Citi Disney price target lowered to $125 from $130 at Citi 05/12/23 Wolfe Research Wolfe downgrades Disney on 'deteriorating' streaming, TV outlooks 05/22/23 Zoom Video sees FY24 EPS $4.25-$4.31, consensus $4.22 05/22/23 Zoom Video sees Q2 EPS $1.04-$1.06, consensus $1.05 05/22/23 Zoom Video reports Q1 EPS $1.16, consensus 99c 05/22/23 Notable companies reporting after market close 05/04/23 Yelp raises FY23 revenue view to $1.295B-$1.315B, consensus $1.3B 05/04/23 Yelp reports Q1 EPS (2c), consensus (5c) 02/09/23 Yelp sees FY23 revenue $1.29B-$1.31B, consensus $1.29B 02/09/23 Yelp reports Q4 EPS 28c, consensus 28c $114.79 / +2.675 (+2.39%)
05/23/23 Williams-Sonoma backs FY23 revenue view down 3% to up 3%, consensus $8.33B 05/23/23 Williams-Sonoma reports Q1 EPS $2.64, consensus $2.37 05/23/23 Vipshop sees Q2 revenue up 10%-15%, consensus 3.79B 05/23/23 Vipshop reports Q1 EPS 46c, consensus 37c 02/23/23 Vipshop sees Q1 revenue flat to up 5%, consensus $3.6B 02/23/23 Vipshop reports Q4 EPS 53c, consensus 47c 05/10/23 Tegna reports Q1 EPS 47c, consensus 47c 02/27/23 Tegna reports Q4 EPS 98c, consensus $1.13 04/25/23 Shutterstock sees FY23 adjusted EPS $4.00-$4.10, consensus $4.03 04/25/23 Shutterstock reports Q1 adjusted EPS $1.29, consensus $1.07 02/09/23 Shutterstock sees 2023 adjuted EPS $3.90-$4.05, consensus $3.50 02/09/23 Shutterstock reports Q4 adjusted EPS $1.05, consensus 95c RYAN Ryan Specialty Group 05/04/23 Ryan Specialty narrows FY23 revenue growth view to 10.5%-13% from 10%-13% 05/04/23 Ryan Specialty Group reports Q1 adjusted EPS 26c, consensus 25c 02/28/23 Ryan Specialty Group sees FY23 organic revenue growth 10%-13%, consensus $2B 02/28/23 Ryan Specialty Group reports Q4 adjusted EPS 27c, consensus 26c 05/11/23 Rain Oncology reports Q1 EPS (56c), consensus (61c) 03/09/23 Rain Oncology reports Q4 EPS (70c), consensus (56c) 05/03/23 Perion Network raises FY23 revenue view to $725M-$745M from $720M-$740M 05/03/23 Perion Network reports Q1 adjusted EPS 60c, consensus 43c 02/08/23 Perion Network sees FY23 revenue $720M-$740M, consensus $730.03M 02/08/23 Perion Network reports Q4 adjusted EPS 90c, consensus 59c $23.13 / +3.085 (+15.39%)
05/03/23 Myriad Genetics narrows FY 23 EPS range to (36c) -(24c) , consensus (32c) 05/03/23 Myriad Genetics reports Q1 EPS (21c), consensus (19c) 02/28/23 Myriad Genetics sees FY23 (40c)-(20c), consensus (30c) 02/28/23 Myriad Genetics sees Q1 EPS (20c)-(18c), consensus (10c) 05/09/23 Microvast sees Q2 revenue $63M-$67M 05/09/23 Microvast raises FY23 revenue view to $348M-$368M 04/26/23 Meta Platforms sees Q2 revenue $29.5B-$32B, consensus $29.48B 04/26/23 Meta Platforms reports Q1 EPS $2.20, consensus $2.53 04/26/23 Notable companies reporting after market close 05/23/23 Lowe's sees $400M headwind to Q2 sales 05/23/23 Lowe's cuts FY23 EPS view to $13.20-$13.60 from 13.60-$14.00, consensus $13.73 05/23/23 Lowe's reports Q1 adjusted EPS $3.67, consensus $3.44 05/22/23 Notable companies reporting before tomorrow's open 05/22/23 JPMorgan now sees FY NII ex-Markets $84B due to First Republic 04/14/23 JPMorgan reports Q1 EPS $4.10, consensus $3.41 04/13/23 Notable companies reporting before tomorrow's open 01/13/23 JPMorgan reports Q4 EPS $3.57, consensus $3.07 04/27/23 Intercept reports Q1 EPS (77c), consensus (65c) 03/02/23 Intercept reports Q4 EPS (50c), consensus (16c) 01/11/23 Intercept sees FY22 net sales of $343M, up 10% y/y IART Integra LifeSciences $43.01 / -7.725 (-15.23%)
05/23/23 Integra LifeSciences sees Q2 adjusted EPS 55c-59c, consensus 77c 04/26/23 Integra LifeSciences sees Q2 adjusted EPS 75c-79c, consensus 85c 04/26/23 Integra LifeSciences backs FY23 adjusted EPS view $3.43-$3.51, consensus $3.48 04/26/23 Integra LifeSciences reports Q1 adjusted EPS 74c, consensus 74c 05/23/23 Dick's Sporting backs FY23 EPS view $12.90-$13.80, consensus $13.44 05/23/23 Dick's Sporting reports Q1 adjusted EPS $3.40, consensus $3.18 05/10/23 Disney reports Q2 EPS ex-items 93c, consensus 93c 05/10/23 Notable companies reporting after market close 02/08/23 Disney reports Q1 EPS ex-items 99c, consensus 78c 02/08/23 Notable companies reporting after market close 04/28/23 Chevron reports Q1 adjusted EPS $3.55, consensus $3.41 04/27/23 Notable companies reporting before tomorrow's open 01/27/23 Chevron reports Q4 adjusted EPS $4.09, consensus $4.38 05/23/23 BJ's Wholesale backs FY23 guidance 05/23/23 BJ's Wholesale reports Q1 adjusted EPS 85c, consensus 85c 03/09/23 BJ's Wholesale provides long-term financial outlook 03/09/23 BJ's Wholesale sees FY23 EPS 'approximately flat y/y,' consensus $3.85 05/18/23 Alibaba reports Q4 EPS $1.56, consensus $1.35 05/17/23 Notable companies reporting before tomorrow's open 02/23/23 Alibaba reports Q3 adjusted EPS $2.79, consensus $2.37 $2,470.00 / -151.08 (-5.76%)
05/23/23 AutoZone reports Q3 EPS $34.12, consensus $31.42 02/28/23 AutoZone reports Q2 EPS $24.64, consensus $21.91 $695.78 / +18.01 (+2.66%)
03/02/23 Broadcom sees Q2 revenue approximately $8.7B, consensus $8.59B 03/02/23 Broadcom reports Q1 adjusted EPS $10.33, consensus $10.10 03/02/23 VMware reports Q4 EPS $2.13, consensus $1.92 03/02/23 Notable companies reporting after market close 04/27/23 Amazon sees Q2 revenue $127B-$133B, consensus $129.83B 04/27/23 Amazon reports Q1 EPS 31c with Rivian loss, consensus 21c 04/27/23 Notable companies reporting after market close 02/02/23 Amazon sees Q1 revenue $121B-$126B, consensus $125.11B 05/02/23 AMD sees Q2 revenue $5.3B +/- $300M, consensus $5.49B 05/02/23 AMD reports Q1 EPS 60c, consensus 56c 05/02/23 Notable companies reporting after market close 05/01/23 Notable companies reporting before tomorrow's open 05/21/23 Fly Intel: Top five weekend stock stories 05/04/23 Apple sees Q3 revenue growth 'similar' to Q2, consensus $84.71B 05/04/23 Apple sees Q3 revenue 'similar' to Q2, consensus $84.71B 05/04/23 Apple reports Q2 EPS $1.52, consensus $1.43
On The Fly
The most talked about and…
Show Hide Related Items >> <<
05/22/23 Zoom Video says Zoom Phone surpassed 10% of revenue in Q1 05/22/23 Zoom Video reports 3,580 customers contributing more than $100,000 in Q1 05/16/23 Zoom Video CFO Steckelberg sells $206K in company shares 05/16/23 Zoom Video partners with Anthropic to expand federated approach to AI WPM Wheaton Precious Metals 03/09/23 Wheaton Precious Metals sees 5-year average gold equivalent production 810KK oz. 02/27/23 Integra Resources, Millennial Precious Metals announce friendly at-market merger 05/12/23 Treasury ties domestically produced steel to IRA tax credit 04/19/23 Steel Dynamics sees 'solid' domestic steel consumption 02/27/23 Steel Dynamics increases quarterly dividend 25% to 42.5c per share 02/09/23 Steel Dynamics names Barry Schneider COO 05/22/23 Rain Oncology Phase 3 MANTRA trial did not meet primary endpoint 01/23/23 Rain Oncology announces publication of Phase 1 data of milademetan 12/29/22 Rain Therapeutics announces name change to Rain Oncology 04/25/23 Quanterix says Toferson results provide support for FDA's accelerated approval 05/16/23 Nuscale Power and Nucor sign MOU for nuclear reactors to power steel mills 05/11/23 Nucor approves repurchase of up to $4B in company shares 04/20/23 Nucor CEO: Nucor's future has never been brighter 04/18/23 Myriad, Intermountain Precision now offer solid tumor testing in all states 04/12/23 Myriad Genetics, SimonMed Imaging collaborate to advance precision medicine 03/02/23 Myriad Genetics, Illumina expand partnership for HRD testing access 03/02/23 Illumina and Myriad Genetics partner for HRD testing in the U.S. MRVI Maravai Lifesciences 05/16/23 Maravai LifeSciences trading resumes 05/16/23 Maravai LifeSciences trading halted, volatility trading pause 05/09/23 Maravai LifeSciences trading resumes 05/09/23 Maravai LifeSciences trading halted, volatility trading pause 05/19/23 Intercept 'disappointed' in outcome of FDA's advisory meeting 05/19/23 Intercept announces outcome of FDA meeting to review NDA for obeticholic acid 05/19/23 FDA panel votes 12-2 against Intercept's pre-cirrhotic fibrosis treatment 05/19/23 Intercept announces Nasdaq halt of trading, FDA advisory committee meeting IART Integra LifeSciences 05/23/23 Integra LifeSciences falls 15% after product recall, Q2 guidance cut 05/23/23 Integra LifeSciences voluntary recalls all products made in Boston plant 01/25/23 Integra LifeSciences confirms Carrie Anderson to step down as CFO 01/25/23 Campbell Soup names Carrie Anderson as new CFO 03/23/23 Five9 expands partnership with Invoca for PreSense solution 03/09/23 Qualtrics and Five9 team to improve contact center experience 01/17/23 Five9 opens new European R&D hub in Porto, Portugal 05/22/23 Chevron to acquire PDC Energy in $6.3B all-stock transaction 05/15/23 Berkshire Hathaway takes stake in Capital One, exits RH 05/15/23 Tiger Management adds Nvidia in Q1, sells out of Toast and Chevron 04/28/23 Chevron expects to repurchase $4.375B in shares in Q2 05/08/23 Cleveland-Cliffs reports successful blast furnace hydrogen injection trial 05/05/23 Cleveland-Cliffs says IAM Local 1943 employees at Middletown Works ratify pact 05/04/23 Cleveland-Cliffs announces pact for Minnesota iron ore mineral leases 04/26/23 Cleveland-Cliffs reaches tentative labor pact with IAM for Middletown Works CCCS CCC Intelligent Solutions 05/09/23 CCC Intelligent Solutions teams with Verisk Analytics for P&C insurance claims 03/22/23 CCC Intelligent announces Indiana Farmers Insurance to use CCC Estimate 02/02/23 Duck Creek welcomes CCC Intelligent Solutions through partner program 04/24/23 Axonics acquired assets of Radian, terms not disclosed 01/31/23 Axonics receives FDA approval for rechargeable sacral neuromodulation system 12/13/22 Axonics announces Health Canada approval of R20 neurostimulator 05/23/23 Piper Sandler Zoom Video price target lowered to $76 from $78 at Piper Sandler 05/23/23 Evercore ISI Zoom Video price target lowered to $75 from $85 at Evercore ISI 05/23/23 Needham Needham stay neutral on Zoom Video pending more visibility on Enterprise growth 05/23/23 RBC Capital Zoom Video Online segment stabilizing but Enterprize slowing, says RBC Capital 05/23/23 Morgan Stanley Chevron price target raised to $198 from $192 at Morgan Stanley 05/23/23 HSBC Chevron upgraded to Buy from Hold at HSBC 05/22/23 KeyBanc KeyBanc expects PDC to trade up toward $70/share after 'surprising' Chevron deal 05/19/23 Mizuho Chevron price target lowered to $196 from $206 at Mizuho 05/23/23 Goldman Sachs Myriad Genetics upgraded to Buy from Sell at Goldman Sachs 03/06/23 Stephens Myriad Genetics price target raised to $24 from $17 at Stephens 01/18/23 Raymond James Myriad Genetics upgraded to Outperform from Market Perform at Raymond James 01/18/23 Raymond James Myriad Genetics upgraded to Outperform from Market Perform at Raymond James 05/23/23 Goldman Sachs Quanterix upgraded to Buy from Neutral at Goldman Sachs 05/15/23 Canaccord Quanterix price target raised to $19 from $13 at Canaccord 08/15/22 Canaccord Quanterix downgraded to Hold from Buy at Canaccord 08/09/22 TD Cowen Quanterix downgraded to Market Perform from Outperform at Cowen CCCS CCC Intelligent Solutions 05/23/23 Evercore ISI Evercore upgrades 'under the radar' CCC Intelligent Solutions to Outperform 05/23/23 Evercore ISI CCC Intelligent Solutions upgraded to Outperform from In Line at Evercore ISI 04/25/23 Jefferies CCC Intelligent Solutions assumed with a Buy at Jefferies 04/13/23 JPMorgan CCC Intelligent Solutions initiated with an Overweight at JPMorgan 05/23/23 BofA Intercept price target lowered to $14 from $17 at BofA 05/23/23 Canaccord Intercept price target lowered to $12 from $26 at Canaccord 05/23/23 Needham Needham downgrades Intercept, says NASH approval 'highly unlikely' 05/23/23 Needham Intercept downgraded to Hold from Buy at Needham 05/23/23 H.C. Wainwright Rain Oncology downgraded to Neutral from Buy at H.C. Wainwright 05/23/23 Oppenheimer Rain Oncology downgraded to Perform on Phase 3 failure at Oppenheimer 05/23/23 Citi Rain Oncology downgraded to Neutral from Buy at Citi 05/22/23 Oppenheimer Rain Oncology downgraded to Perform from Outperform at Oppenheimer IART Integra LifeSciences 05/23/23 Citi Citi downgrades Integra to Sell, sees further guidance cuts 05/23/23 Citi Integra LifeSciences downgraded to Sell from Neutral at Citi 05/18/23 Truist Integra LifeSciences price target lowered to $54 from $58 at Truist 04/27/23 JMP Securities Integra LifeSciences price target lowered to $65 from $75 at JMP Securities MRVI Maravai Lifesciences 05/23/23 Credit Suisse Maravai Lifesciences downgraded to Neutral from Outperform at Credit Suisse 05/09/23 Deutsche Bank Maravai Lifesciences price target lowered to $23 from $25 at Deutsche Bank 05/09/23 Goldman Sachs Maravai Lifesciences downgraded to Neutral at Goldman after guidance cut 05/09/23 Goldman Sachs Maravai Lifesciences downgraded to Neutral from Buy at Goldman Sachs WPM Wheaton Precious Metals 05/23/23 RBC Capital Wheaton Precious Metals cut to Sector Perform at RBC Capital on valuation 05/23/23 RBC Capital Wheaton Precious Metals downgraded to Sector Perform from Outperform at RBC Capital 05/08/23 National Bank Wheaton Precious Metals price target raised to C$80 at National Bank 04/21/23 Barclays Wheaton Precious Metals price target raised to $43 from $42 at Barclays 05/23/23 JPMorgan Steel Dynamics initiated with an Underweight at JPMorgan 05/05/23 UBS Steel Dynamics price target lowered to $100 from $110 at UBS 04/21/23 Credit Suisse Steel Dynamics price target raised to $115 from $106 at Credit Suisse 04/05/23 BofA Steel Dynamics downgraded to Neutral from Buy at BofA 05/23/23 JPMorgan Nucor initiated with an Underweight at JPMorgan 05/05/23 UBS Nucor price target lowered to $140 from $145 at UBS 03/17/23 Credit Suisse Nucor price target raised to $156 from $140 at Credit Suisse 03/15/23 Citi Steel Dynamics downgraded to Neutral from Buy at Citi 05/23/23 JPMorgan Cleveland-Cliffs initiated with a Neutral at JPMorgan 03/20/23 Wolfe Research Cleveland-Cliffs upgraded to Peer Perform from Underperform at Wolfe Research 02/15/23 B. Riley Cleveland-Cliffs price target lowered to $26 from $27 at B. Riley 01/31/23 B. Riley Cleveland-Cliffs Q4 likely to represent trough earnings, says B. Riley 05/23/23 Roth MKM Five9 resumed with a Buy at Roth MKM 05/05/23 Canaccord Five9 price target lowered to $80 from $90 at Canaccord 03/23/23 Rosenblatt Five9 initiated with a Buy at Rosenblatt 02/23/23 Deutsche Bank Five9 price target raised to $70 from $55 at Deutsche Bank 05/23/23 CL King Axonics initiated with Buy on 'underpenetrated markets' at CL King 05/23/23 CL King Axonics initiated with a Buy at CL King 05/02/23 Needham Axonics price target raised to $73 from $71 at Needham 04/17/23 Truist Axonics price target lowered to $73 from $82 at Truist 05/22/23 Zoom Video sees FY24 EPS $4.25-$4.31, consensus $4.22 05/22/23 Zoom Video sees Q2 EPS $1.04-$1.06, consensus $1.05 05/22/23 Zoom Video reports Q1 EPS $1.16, consensus 99c 05/22/23 Notable companies reporting after market close WPM Wheaton Precious Metals 05/04/23 Wheaton Precious Metals reports Q1 EPS 25c, consensus 25c 03/09/23 Wheaton Precious Metals reports Q4 adjusted EPS 23c, consensus 35c 04/19/23 Steel Dynamics reports Q1 adjusted EPS $4.01, consensus $3.52 03/15/23 Steel Dynamics sees Q1 adjusted EPS $3.78-$3.82, consensus $3.11 01/25/23 Steel Dynamics reports Q4 adjusted EPS $4.37, consensus $3.79 12/15/22 Steel Dynamics sees Q4 adjusted EPS $4.10-$4.14, consensus $3.84 05/11/23 Rain Oncology reports Q1 EPS (56c), consensus (61c) 03/09/23 Rain Oncology reports Q4 EPS (70c), consensus (56c) 05/09/23 Quanterix sees FY23 revenue $104M-$111M, consensus $106.7M 05/09/23 Quanterix reports Q1 EPS (16c), consensus (38c) 03/06/23 Quanterix reports Q4 EPS (50c), consensus (47c) 04/20/23 Nucor expects Q2 earnings to increase compared to Q1, consensus $5.21 04/20/23 Nucor reports Q1 EPS $4.45, consensus $3.81 03/16/23 Nucor sees Q1 EPS $3.70-$3.80, consensus $3.84 01/26/23 Nucor reports Q4 EPS $4.89, consensus $4.19 05/03/23 Myriad Genetics narrows FY 23 EPS range to (36c) -(24c) , consensus (32c) 05/03/23 Myriad Genetics reports Q1 EPS (21c), consensus (19c) 02/28/23 Myriad Genetics sees FY23 (40c)-(20c), consensus (30c) 02/28/23 Myriad Genetics sees Q1 EPS (20c)-(18c), consensus (10c) MRVI Maravai Lifesciences 05/08/23 Maravai Lifesciences sees FY23 EPS 27c-33c, consensus 35c 05/08/23 Maravai Lifesciences reports Q1 adjusted EPS 3c, consensus 4c 02/22/23 Maravai Lifesciences sees FY23 revenue $$420M-$460M, consensus $432.94M 02/22/23 Maravai Lifesciences reports Q4 EPS 35c, consensus 34c 04/27/23 Intercept reports Q1 EPS (77c), consensus (65c) 03/02/23 Intercept reports Q4 EPS (50c), consensus (16c) 01/11/23 Intercept sees FY22 net sales of $343M, up 10% y/y IART Integra LifeSciences 05/23/23 Integra LifeSciences sees Q2 adjusted EPS 55c-59c, consensus 77c 04/26/23 Integra LifeSciences sees Q2 adjusted EPS 75c-79c, consensus 85c 04/26/23 Integra LifeSciences backs FY23 adjusted EPS view $3.43-$3.51, consensus $3.48 04/26/23 Integra LifeSciences reports Q1 adjusted EPS 74c, consensus 74c 05/04/23 Five9 raises FY23 EPS view to $1.73-$1.77, consensus $1.69 05/04/23 Five9 sees Q2 EPS 38c-40c, consensus 32c 05/04/23 Five9 reports Q1 EPS 41c, consensus 24c 05/04/23 Notable companies reporting after market close 04/28/23 Chevron reports Q1 adjusted EPS $3.55, consensus $3.41 04/27/23 Notable companies reporting before tomorrow's open 01/27/23 Chevron reports Q4 adjusted EPS $4.09, consensus $4.38 04/24/23 Cleveland-Cliffs reports Q1 EPS (11c), consensus (19c) 04/11/23 Cleveland-Cliffs reports preliminary Q1 revenue $5.2B, consensus $5.21B 02/13/23 Cleveland-Cliffs reports Q4 EPS (30c) excluding charges, consensus (30c) 02/13/23 Cleveland-Cliffs reports Q4 EPS (41c), consensus (30c) CCCS CCC Intelligent Solutions 05/02/23 CCC Intelligent Solutions narrows FY23 revenue to $844M-$850M, consensus $846.6M 05/02/23 CCC Intelligent Solutions sees Q2 revenue $207.5M-$209.5M, consensus 208.6M 05/02/23 CCC Intelligent Solutions reports Q1 EPS 7c, consensus 7c 03/01/23 CCC Intelligent Solutions sees FY23 revenue $842M-$850M, consensus $844.96M 05/01/23 Axonics raises FY23 revenue view to $348M from $324M, consensus $347.8M 05/01/23 Axonics reports Q1 EPS (19c), consensus (29c) 03/01/23 Axonics backs FY23 revenue view of $342M, consensus $336.4M 03/01/23 Axonics reports Q4 EPS 1c, consensus (24c)
Downgrade
H.C. Wainwright analyst…
H.C. Wainwright analyst Mitchell Kapoor downgraded Rain Oncology to Neutral from Buy without a price target saying the Phase 3 liposarcoma data disappointed. The firm awaits further clarity on the path forward and the resources required to execute on this plan as well as the residual value of milademetan.
Show Hide Related Items >> <<
05/22/23 Rain Oncology Phase 3 MANTRA trial did not meet primary endpoint 01/23/23 Rain Oncology announces publication of Phase 1 data of milademetan 12/29/22 Rain Therapeutics announces name change to Rain Oncology 05/23/23 Oppenheimer Rain Oncology downgraded to Perform on Phase 3 failure at Oppenheimer 05/23/23 Citi Rain Oncology downgraded to Neutral from Buy at Citi 05/22/23 Oppenheimer Rain Oncology downgraded to Perform from Outperform at Oppenheimer 05/22/23 Piper Sandler Piper downgrades Rain Oncology to Neutral, removing all value for milademetan 05/11/23 Rain Oncology reports Q1 EPS (56c), consensus (61c) 03/09/23 Rain Oncology reports Q4 EPS (70c), consensus (56c) 05/22/23 What You Missed On Wall Street On Monday 05/22/23 What You Missed On Wall Street This Morning
